StarSource Multitrade Closes Trading Window Ahead of Audited FY26 Results

StarSource Multitrade Limited has announced the closure of its trading window starting April 1, 2026. This step is to prevent insider trading before its audited financial results for the quarter and year ending March 31, 2026.

Key Filing Details

StarSource Multitrade Limited is closing its trading window for designated persons, including promoters, directors, and key management.

The closure begins April 1, 2026, and lasts until two clear trading days after the audited financial results for the quarter and year ended March 31, 2026, are announced.

This is a standard procedure required by SEBI to prevent insider trading around significant disclosures.

The company will announce the date of its Board Meeting to approve these financial results soon.

Why the Closure Matters

The trading window closure is required under SEBI's Prohibition of Insider Trading (PIT) Regulations.

This ensures individuals with access to unpublished price-sensitive information (UPSI), like financial results, cannot trade the company's shares before the information is public.

This supports market integrity and ensures fair trading for all investors.

Company Background

StarSource Multitrade Limited, previously known as Chemo Pharma Laboratories Ltd., has a history dating back to its 1942 incorporation.

Initially a pharmaceutical firm, the company has since transformed and diversified significantly.

Today, it operates in diverse areas like wholesale trading, agro products, scrap trading, railway contracts, and precious metals.

The company has also signaled intentions to diversify further, possibly by acquiring businesses in the power and chemicals sectors.

In October 2025, it officially changed its name from Chemo Pharma Laboratories Ltd. to StarSource Multitrade Limited, reflecting its changing business strategy.

Trading Restrictions

• Designated persons, including promoters, directors, and key management, are barred from trading StarSource Multitrade's shares or securities.
• This restriction aims to ensure fairness as the company approaches its annual audited financial results announcement.
• The trading window will reopen only after the financial results are officially released to the public.

Regulatory Considerations

While this is routine compliance, adherence to SEBI's insider trading rules is crucial for corporate governance.

Any failure to comply could lead to regulatory scrutiny.

Comparable Companies

StarSource Multitrade operates across diverse sectors, making direct peer comparison difficult.

However, companies like MMTC Limited (diversified trading), Andrew Yule & Co. Ltd. (diversified conglomerate), and Capri Global Capital Ltd. (diversified financial services) have diversified operations or expansion strategies.

Trading window closures are standard practice for most listed Indian companies, including these peers, to comply with SEBI regulations.

Previous Financial Reporting

• The company previously announced its Board Meeting for Unaudited Financial Results (for the quarter and nine months ended Dec 31, 2025) on February 12, 2026.

What Investors Should Watch

• The date of the Board Meeting to approve the audited FY26 financial results.
• The official release date for the audited FY26 financial results.
• When the trading window reopens after the results are announced.